Glenn E. Simmons Jr

Dr. Glenn E. Simmons Jr

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Cellular Signalling
Verified
Journal Article
Closed access
MSMonica Sharma
Monica Sharma
ICIsabel Castro-Piedras
Isabel Castro-Piedras
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
KPKevin Pruitt
Kevin Pruitt

Verified
Journal Article
Open access
PDF file
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
WPWendy M. Pruitt
Wendy M. Pruitt
KPKevin Pruitt
Kevin Pruitt
SIRT1, an NAD+-dependent deacetylase, has been described in the literature as a major player in the regulation of cellular stress responses. Its expression has been shown to be altered in cancer cells, and it targets both histone and non-histone proteins for deacetylation and thereby alters metabolic programs in response to diverse physiological stress. Interestingly, many of the metabolic pathways that are influenced by SIRT1 are also altered in tumor development. Not only does SIRT1 have the potential to regulate oncogenic factors, it also orchestrates many aspects of metabolism and lipid regulation and recent reports are beginning to connect these areas. SIRT1 influences pathways that provide an alternative means of deriving energy (such as fatty acid oxidation and gluconeogenesis) when a cell encounters nutritive stress, and can therefore lead to altered lipid metabolism in various pathophysiological contexts. This review helps to show the various connections between SIRT1 and major pathways in cellular metabolism and the consequence of SIRT1 deregulation on carcinogenesis and lipid metabolism.

4 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
SPSomnath Pandey
Somnath Pandey
ANAna Nedeljkovic-Kurepa
Ana Nedeljkovic-Kurepa
MSMadhurima Saxena
Madhurima Saxena
AWAllison Wang
Allison Wang
KPKevin Pruitt
Kevin Pruitt
The Wnt signaling pathway is often chronically activated in diverse human tumors, and the Frizzled (FZD) family of receptors for Wnt ligands, are central to propagating oncogenic signals in a β-catenin-dependent and independent manner. SIRT1 is a class III histone deacetylase (HDAC) that deacetylates histone and non-histone proteins to regulate gene transcription and protein function. We previously demonstrated that SIRT1 loss of function led to a significant decrease in the levels of Dishevelled (Dvl) proteins. To further explore this connection between the sirtuins and components of the Wnt pathway, we analyzed sirtuin-mediated regulation of FZD proteins. Here we explore the contribution of sirtuin deacetylases in promoting constitutive Wnt pathway activation in breast cancer cells. We demonstrate that the use of small molecule inhibitors of SIRT1 and SIRT2, and siRNA specific to SIRT1, all reduce the levels of FZD7 mRNA. We further demonstrate that pharmacologic inhibition of SIRT1/2 causes a marked reduction in FZD7 protein levels. Additionally, we show that β-catenin and c-Jun occupy the 7 kb region upstream of the transcription start site of the FZD7 gene, and SIRT1 inhibition leads to a reduction in the occupancy of both β-catenin and c-Jun at points along this region. This work uncovers a new mechanism for the regulation of FZD7 and provides a critical new link between the sirtuins and FZD7, one of the earliest nodal points from which oncogenic Wnt signaling emanates. This study shows that inhibition of specific sirtuins may provide a unique strategy for inhibiting the constitutively active Wnt pathway at the level of the receptor.

25 May 2022 in Oncotarget
Verified
Journal Article
Open access
PDF file
SCSaliha Chaudhry
Saliha Chaudhry
STStefani N. Thomas
Stefani N. Thomas
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
Https://doi.org/10.18632/oncotarget.28241 Saliha Chaudhry, Stefani N. Thomas, Glenn E. Simmons Jr.

28 May 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
HTHarry Taylor
Harry Taylor
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
TMThomas P. Mathews
Thomas P. Mathews
AKAtanu K. Khatua
Atanu K. Khatua
WPWaldemar Popik
Waldemar Popik
HBH. Alex Brown
H. Alex Brown
Quiescent CD4+ T cells restrict human immunodeficiency virus type 1 (HIV-1) infection at early steps of virus replication. Low levels of both deoxyribonucleotide triphosphates (dNTPs) and the biosynthetic enzymes required for their de novo synthesis provide one barrier to infection. CD4+ T cell activation induces metabolic reprogramming that reverses this block and facilitates HIV-1 replication. Here, we show that phospholipase D1 (PLD1) links T cell activation signals to increased HIV-1 permissivity by triggering a c-Myc-dependent transcriptional program that coordinates glucose uptake and nucleotide biosynthesis. Decreasing PLD1 activity pharmacologically or by RNA interference diminished c-Myc-dependent expression during T cell activation at the RNA and protein levels. PLD1 inhibition of HIV-1 infection was partially rescued by adding exogenous deoxyribonucleosides that bypass the need for de novo dNTP synthesis. Moreover, the data indicate that low dNTP levels that impact HIV-1 restriction involve decreased synthesis, and not only increased catabolism of these nucleotides. These findings uncover a unique mechanism of action for PLD1 inhibitors and support their further development as part of a therapeutic combination for HIV-1 and other viral infections dependent on host nucleotide biosynthesis. Replication of all human viruses depends on building blocks derived from the metabolic pathways of the infected host cell. The production of progeny virions requires synthesis of viral nucleic acids from deoxyribonucleotide triphosphates (dNTPs). HIV-1 infection in resting T cells is limited, at least in part, because the levels of critical nucleotides are low. However, stimulation of T cells turns on their metabolic machinery to increase c-Myc expression and subsequent synthesis of these key components of RNA and DNA, which augments HIV-1 replication. We have identified PLD1 as a key molecular switch that couples stimulatory T cell signals to c-Myc-dependent nucleotide biosynthesis. We also found that a small molecule that inhibits PLD1 suppresses HIV-1 replication by limiting c-Myc-dependent effects of T cell activation that support efficient HIV reverse transcription. Our study provides insight into a novel way of targeting T cell activation-induced processes such as nucleotide biosynthesis that has potential to augment current therapeutics for HIV-1.

25 April 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SCShaojie Cui
Shaojie Cui
GJGlenn E. Simmons Jr
Glenn E. Simmons Jr
GVGoncalo Vale
Goncalo Vale
YDYaqin Deng
Yaqin Deng
JKJungyeon Kim
Jungyeon Kim
Jin YeJin Ye
Jin Ye
Significance: The current study reveals the functions of FAF1 in protecting cells from ferroptosis, a novel cell death pathway triggered by PUFA peroxidation. In the absence of FAF1, cultured cells and mice are extremely sensitive to ferroptosis when exposed to physiological levels of PUFAs. Mechanistically, FAF1 sequesters PUFAs into the hydrophobic core of a global structure that limits their access to positively charged Fe 2+ , which catalyzes the peroxidation reaction. These observations suggest that FAF1-mediated protection of PUFA peroxidation plays a critical role in preventing initiation of ferroptosis.